Benefits
Generalized Anxiety Disorder (GAD)
RCT compared passionflower 45 drops/day vs oxazepam 30 mg/day for GAD over 4 weeks — equivalent anxiolytic efficacy with fewer side effects (less impairment of work performance) than oxazepam. Strongest single piece of evidence for passionflower anxiolysis.
Pre-Surgical / Pre-Procedural Anxiety
trial showed passionflower (Passipay) 500 mg given 90 minutes pre-surgery significantly reduced pre-operative anxiety vs placebo without delaying recovery. Useful for medical/dental procedure anxiety.
Sleep Quality and Onset
trial showed passionflower tea modestly improved sleep quality scores in healthy adults with mild sleep concerns. Effect modest. Often combined with valerian, lemon balm, hops in sleep formulations.
Opioid Withdrawal Adjunct
Akhondzadeh 2001 (separate trial) showed passionflower + clonidine more effective than clonidine alone for opioid withdrawal symptoms. Suggests benefit for withdrawal-associated anxiety.
ADHD Symptoms (Limited Evidence)
trial showed passionflower comparable to methylphenidate for some ADHD symptoms with fewer side effects in children — small study; not standard ADHD treatment.
Mechanism of action
GABA-A Receptor Modulation
Passionflower flavonoids (chrysin, apigenin, vitexin) bind benzodiazepine site of GABA-A receptor — mild positive allosteric modulators. Mechanism similar to benzodiazepines but much weaker affinity. Basis for anxiolytic and sleep effects.
Direct GABA Content
Passiflora plants contain GABA itself (the inhibitory neurotransmitter) — though oral GABA's CNS penetration is limited, passionflower's GABA content may contribute to local effects.
Harman Alkaloid MAO Inhibition (Modest)
Passionflower contains small amounts of beta-carbolines (harman, harmine, harmaline) with mild MAO inhibition — may modestly affect monoamine neurotransmitters. Generally not clinically significant at typical doses.
Chrysin Anxiolytic Activity
Chrysin (5,7-dihydroxyflavone) is a key passionflower flavonoid with anxiolytic effects — tested as a stand-alone anxiolytic. Aromatase inhibition is theoretical at high doses.
Clinical trials
Double-blind RCT comparing passionflower extract (45 drops/day) vs oxazepam (30 mg/day) in 36 GAD patients for 4 weeks.
36 GAD patients.
Equivalent anxiolytic efficacy. Oxazepam group had more impairment of job performance. Established passionflower as reasonable alternative to mild benzodiazepines for GAD.
RCT of passionflower (Passipay 500 mg) 90 minutes pre-surgery vs placebo in 60 patients undergoing surgery.
60 surgical patients.
Significantly reduced pre-operative anxiety; no delay in psychomotor recovery. Established passionflower as practical pre-procedural anxiolytic.